Acceleron Pharma Inc Revenue Q/Q
What is the Revenue Q/Q of Acceleron Pharma Inc?
The Revenue Q/Q of Acceleron Pharma Inc is 51.58%
What is the definition of Revenue Q/Q?
Quarterly revenue growth, year over year, is the increase of a company’s revenue compared to the performance in the corresponding quarter of a previous year expressed as a percentage.
quarterly growth yoy (year over year)
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
Revenue Q/Q of companies in the Health Care sector on NASDAQ compared to Acceleron Pharma Inc
What does Acceleron Pharma Inc do?
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Companies with revenue q/q similar to Acceleron Pharma Inc
- Skipper has Revenue Q/Q of 51.50%
- TCS PLC has Revenue Q/Q of 51.50%
- Hemisphere has Revenue Q/Q of 51.50%
- 1st has Revenue Q/Q of 51.52%
- Metro Mining has Revenue Q/Q of 51.52%
- Shanthi Gears has Revenue Q/Q of 51.53%
- Acceleron Pharma Inc has Revenue Q/Q of 51.58%
- Gujarat Fluorochemicals has Revenue Q/Q of 51.59%
- Star Equity has Revenue Q/Q of 51.61%
- Persistent Systems has Revenue Q/Q of 51.61%
- Starcore International Mines has Revenue Q/Q of 51.62%
- Bombardier has Revenue Q/Q of 51.62%
- Morses Club PLC has Revenue Q/Q of 51.64%